Search Results - "Casares, Maria Teresa Gomez"

High resolution melting analysis: a rapid and accurate method to detect CALR mutations by Bilbao-Sieyro, Cristina, Santana, Guillermo, Moreno, Melania, Torres, Laura, Santana-Lopez, Gonzalo, Rodriguez-Medina, Carlos, Perera, María, Bellosillo, Beatriz, de la Iglesia, Silvia, Molero, Teresa, Gomez-Casares, Maria Teresa

“…The recent discovery of CALR mutations in essential thrombocythemia (ET) and primary myelofibrosis (PMF) patients without JAK2/MPL mutations has emerged as a…”
Get full text

Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis by Mosquera‐Orgueira, Adrián, Pérez‐Encinas, Manuel, Hernández‐Sánchez, Alberto, González‐Martínez, Teresa, Arellano‐Rodrigo, Eduardo, Martínez‐Elicegui, Javier, Villaverde‐Ramiro, Ángela, Raya, José‐María, Ayala, Rosa, Ferrer‐Marín, Francisca, Fox, María‐Laura, Velez, Patricia, Mora, Elvira, Xicoy, Blanca, Mata‐Vázquez, María‐Isabel, García‐Fortes, María, Angona, Anna, Cuevas, Beatriz, Senín, María‐Alicia, Ramírez‐Payer, Angel, Ramírez, María‐José, Pérez‐López, Raúl, González de Villambrosía, Sonia, Martínez‐Valverde, Clara, Gómez‐Casares, María‐Teresa, García‐Hernández, Carmen, Gasior, Mercedes, Bellosillo, Beatriz, Steegmann, Juan‐Luis, Álvarez‐Larrán, Alberto, Hernández‐Rivas, Jesús María, Hernández‐Boluda, Juan Carlos

“…Myelofibrosis (MF) is a myeloproliferative neoplasm (MPN) with heterogeneous clinical course. Allogeneic hematopoietic cell transplantation remains the only…”
Get full text

PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase by Alonso-Dominguez, Juan M, Casado, Luis Felipe, Anguita, Eduardo, Gomez-Casares, Maria Teresa, Buño, Ismael, Ferrer-Marín, Francisca, Arenas, Alicia, Del Orbe, Rafael, Ayala, Rosa, Llamas, Pilar, Salgado, Rocio N, Osorio, Santiago, Sanchez-Godoy, Pedro, Burgaleta, Carmen, Mahíllo-Fernández, Ignacio, Garcia-Gutierrez, Valentin, Steegmann, Juan Luis, Martinez-Lopez, Joaquín

“…Patched homolog 1 gene (PTCH1) expression and the ratio of PTCH1 to Smoothened (SMO) expression have been proposed as prognostic markers of the response of…”
Get full text

Integrating AIPSS‐MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis by Mosquera‐Orgueira, Adrián, Arellano‐Rodrigo, Eduardo, Garrote, Marta, Martín, Iván, Pérez‐Encinas, Manuel, Gómez‐Casares, María‐Teresa, Hernández‐Sánchez, Alberto, Ferrer‐Marín, Francisca, Mora, Elvira, Velez, Patricia, Ayala, Rosa, Angona, Anna, Heras, Natalia de las, Magro, Elena, Pérez‐Míguez, Carlos, Crucitti, Davide, Mata‐Vázquez, María‐Isabel, Fox, María‐Laura, González de Villambrosía, Sonia, Ramírez, María‐José, García, Ana, García‐Gutiérrez, Valentín, Cáceres, Amparo, Durán, María‐Antonia, Senín, María‐Alicia, Raya, José‐María, González, José A., Cuevas, Beatriz, Xicoy, Blanca, Nangalia, Jyoti, Hernández‐Rivas, Jesús M., Bellosillo, Beatriz, Álvarez‐Larrán, Alberto, Hernández‐Boluda, Juan C.

“…[...]the potential improvement of our ML model's prognostic accuracy by incorporating molecular data on additional somatic mutations could not be adequately…”
Get full text

Prognostic risk models for transplant decision-making in myelofibrosis by Hernández-Boluda, Juan-Carlos, Pereira, Arturo, Correa, Juan-Gonzalo, Alvarez-Larrán, Alberto, Ferrer-Marín, Francisca, Raya, José-María, Martínez-López, Joaquín, Velez, Patricia, Pérez-Encinas, Manuel, Estrada, Natalia, García-Gutiérrez, Valentín, Fox, María-Laura, Payer, Angel, Kerguelen, Ana, Cuevas, Beatriz, Durán, María-Antonia, Ramírez, María-José, Gómez-Casares, María-Teresa, Mata-Vázquez, María-Isabel, Mora, Elvira, Gómez, Montse, Cervantes, Francisco

“…Prognostic models are widely used in clinical practice for transplant decision-making in myelofibrosis (MF). We have compared the performance of the…”
Get full text

An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase by Steegmann, Juan Luis, Colomer, Dolors, Gómez-Casares, Maria-Teresa, García-Gutiérrez, Valentín, Ortí, Guillermo, Ramírez-Payer, Angel, Olavarria, Eduardo, Vall-llovera, Ferrán, Giraldo, Pilar, Conde, Eulogio, Vallansot, Rolando, López-Lorenzo, Jose Luis, Palomera, Luis, Álvarez-Larrán, Alberto, Conesa, Venancio, Bautista, Guiomar, Casas, Laura, Giles, Frank, Hochhaus, Andreas, Casado-Montero, Luis Felipe

“…Purpose This study was aimed to analyze the association of very early molecular response to nilotinib with the achievement of deep molecular response (MR4) at…”
Get full text

Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: A new role in the treatment of leukaemia for these agents by De la Iglesia Iñigo, Silvia, López-Jorge, Carmen Elsa, Gómez-Casares, Maria Teresa, Lemes Castellano, Angelina, Martín Cabrera, Pedro, López Brito, Jezabel, Suárez Cabrera, Alexia, Molero Labarta, Teresa

“…Abstract Renin–angiotensin system (RAS) in the bone marrow is related to proliferation and cellular differentiation. We investigated the effect of ACE…”
Get full text

Acute neurologic deterioration in a patient with asymptomatic Charcot-Marie-Tooth disease following three doses of Brentuximab-Vedotin by de la Nuez Melián, Haridian, Luzardo Henríquez, Hugo, Suárez Cabrera, Alexia, Stuckey, Ruth, Gómez-Casares, María Teresa

Get full text

Discontinuation of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: a Review of the Biological Factors Associated with Treatment-Free Remission by Stuckey, Ruth, López Rodríguez, Juan Francisco, Gómez-Casares, María Teresa

“…Purpose of Review Clinical factors alone do not enable us to differentiate which patients will maintain treatment-free remission (TFR) from those who are…”
Get full text

Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis by Pastor-Galán, Irene, Pereira, Arturo, Arellano-Rodrigo, Eduardo, Martín, Iván, Mosquera-Orgueira, Adrián, Gómez-Casares, María-Teresa, Hernández-Sánchez, Alberto, Ferrer-Marín, Francisca, Mora, Elvira, Velez, Patricia, Ayala, Rosa, Angona, Anna, de las Heras, Natalia, Magro, Elena, Mata-Vázquez, María-Isabel, Fox, María-Laura, González de Villambrosía, Sonia, Ramírez, María-José, García, Ana, García-Gutiérrez, Valentín, Cáceres, Amparo, Durán, María-Antonia, Senín, María-Alicia, Raya, José-María, González, José Antonio, Cuevas, Beatriz, Xicoy, Blanca, Garrote, Marta, Ferrer, Blanca, Pérez-Encinas, Manuel, Hernández-Rivas, Jesús María, Bellosillo, Beatriz, Álvarez-Larrán, Alberto, Hernández-Boluda, Juan Carlos

Get full text

CALR mutation characterization in myeloproliferative neoplasms by Bilbao-Sieyro, Cristina, Florido, Yanira, Gómez-Casares, María Teresa

“…Identification of somatic frameshift mutations in exon 9 of the calreticulin gene (CALR) in myeloproliferative neoplasms (MPNs) in December of 2013 has been a…”
Get full text

Integration of molecular testing for the personalized management of patients with diffuse large B-cell lymphoma and follicular lymphoma by Stuckey, Ruth, Luzardo Henríquez, Hugo, de la Nuez Melian, Haridian, Rivero Vera, José Carlos, Bilbao-Sieyro, Cristina, Gómez-Casares, María Teresa

“…Diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) are the most common forms of aggressive and indolent lymphoma, respectively. The majority of…”
Get full text

Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia by Stuckey, Ruth, López-Rodríguez, Juan Francisco, Sánchez-Sosa, Santiago, Segura-Díaz, Adrián, Sánchez-Farías, Nuria, Bilbao-Sieyro, Cristina, Gómez-Casares, María Teresa

“…Clinical trials have demonstrated that some patients with chronic myeloid leukemia (CML) treated for several years with tyrosine kinase inhibitors (TKIs) who…”
Get full text

PB1893: CLONAL EVOLUTION WITH BCL‐2 AMPLIFICATION DURING VENETOCLAX TREATMENT by Rodríguez‐Afonso, Jorge, Reyes‐González‐Casanova, Paula, Álvarez, Miguel Ángel Perera, Bilbao, Cristina, Stuckey, Ruth, López, Juan Francisco Rodríguez, Medina, Carlos Rodriguez, Ortega, Yanira Florido, Cionfrini, Antonia, Sosa, Santiago Sánchez, Casares, Maria Teresa Gomez

Get full text

PB1754: HOMOZYGOUS DELETION OF ETV6: EARLY T‐CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA OR PRECURSOR T‐LYMPHOBLASTIC LYMPHOMA by Álvarez, Miguel Ángel Perera, López, Juan Francisco Rodríguez, Rodríguez‐Afonso, Jorge, Reyes‐González‐Casanova, Paula, Suarez, Dolly Viviana Fiallo, Castellano, Maria Angelina Lemes, Ballester, Maria Violeta Vidal, Stuckey, Ruth, Medina, Carlos Rodriguez, Bilbao, Cristina, Casares, Maria Teresa Gomez

Get full text

Treatment‐free remission after dasatinib in patients with chronic myeloid leukaemia in chronic phase with deep molecular response: Final 5‐year analysis of DASFREE by Shah, Neil P., García‐Gutiérrez, Valentín, Jiménez‐Velasco, Antonio, Larson, Sarah M., Saussele, Susanne, Rea, Delphine, Mahon, François‐Xavier, Levy, Moshe Yair, Gómez‐Casares, María Teresa, Mauro, Michael J., Sy, Oumar, Martin‐Regueira, Patricia, Lipton, Jeffrey H.

“…Summary Patients with chronic myeloid leukaemia in chronic phase (CML‐CP) who have a sustained deep molecular response (DMR) are eligible to discontinue…”
Get full text

PB1779: FLT3‐ITD MUTATION CHARACTERIZATION WITH CLASSICAL PCR METHODOLOGY VERSUS CAPTURE‐ AND AMPLICON‐BASED NGS PLATFORMS: A PETHEMA NGS‐AML PROJECT by Bilbao, Cristina, Stuckey, Ruth, Sargas, Claudia, Larráyoz, María J, Chillon, Maria Carmen, Diaz, Rosa Ayala, Carrillo, Estrella Cruz, Yébenes‐Ramírez, Manuel, Martinez‐Cuadron, David, Rodriguez‐Veiga, Rebeca, Gil, Cristina, Bernal, Teresa, Burgues, Juan Miguel Bergua, Algarra, Lorenzo, Tormo, Mar, Sanchez, Maria Pilar Martinez, Saldise, Elena Soria, Serrano, Josefina, Dominguez, Juan Manuel Alonso, Boyero, Raimundo Garcia, Amigo, Maria Luz, Herrera‐Puente, Pilar, Sayas, Maria J, Rubira, Esperanza Lavilla, Medina, Carlos Rodriguez, Sosa, Santiago Sánchez, Rodríguez‐Afonso, Jorge, Reyes‐González‐Casanova, Paula, Rodríguez‐Arbolí, Eduardo, Garcia, Joaquin Sanchez, Martinez‐Lopez, Joaquín, García‐Sanz, Ramón, Calasanz, Maria Jose, Barragan, Eva, Casares, Maria Teresa Gomez, Montesinos, Pau

Get full text

Validation of thrombotic risk factors in 1381 patients with essential thrombocythaemia: A multicentre retrospective real‐life study by Stuckey, Ruth, Ianotto, Jean‐Christophe, Santoro, Marco, Czyż, Anna, Perez Encinas, Manuel M., Gómez‐Casares, María Teresa, Noya Pereira, Maria Soledad, Nałęcz, Anna Kulikowska, Gołos, Aleksandra, Lewandowski, Krzysztof, Szukalski, Łukasz, González‐Martín, Jesús M., Wróbel, Tomasz, Sobas, Marta Anna

“…Summary Thrombosis and haemorrhage are frequent in patients with essential thrombocythaemia (ET). The 2016 revised International Prognostic Score for…”
Get full text

Cauda equina syndrome secondary to extramedullary erythropoiesis in a transfusion‐dependent thalassemia patient following treatment with luspatercept: A case report by Iglesia Iñigo, Silvia, Navarrete Bullón, Laura, Stuckey, Ruth, Veiga Vaz, Álvaro, Perera, María del Mar, Hernández Hernández, María, Sosa Pérez, Coralia, Lloret Saez‐Bravo, Marta, Juan Rodríguez, Lucía, González Hernández, Lidia, López Vega, José María, Cabezas de la Cruz, Marcos Antonio, Gómez‐Casares, María Teresa

Get full text

The prognostic impact of non‐driver gene mutations and variant allele frequency in primary myelofibrosis by Hernández‐Sánchez, Alberto, Villaverde‐Ramiro, Ángela, Arellano‐Rodrigo, Eduardo, Garrote, Marta, Martín, Iván, Mosquera‐Orgueira, Adrián, Gómez‐Casares, María‐Teresa, Ferrer‐Marín, Francisca, Such, Esperanza, Velez, Patricia, Ayala, Rosa, Angona, Anna, Heras, Natalia, Magro, Elena, Mata‐Vázquez, María‐Isabel, Fox, María‐Laura, Villambrosía, Sonia González, Ramírez, María‐José, García, Ana, García‐Gutiérrez, Valentín, Cáceres, Amparo, Durán, María‐Antonia, Senín, Alicia, Raya, José‐María, González, José Antonio, Cuevas, Beatriz, Xicoy, Blanca, Pérez‐Encinas, Manuel, Bellosillo, Beatriz, Álvarez‐Larrán, Alberto, Hernández‐Rivas, Jesús María, Hernández‐Boluda, Juan Carlos

“…Prognostic impact of non‐MPN driver gene mutations in primary myelofibrosis. MIPSS70: Mutation‐Enhanced International Prognostic Score System…”
Get full text